How should Barrett's ulceration be treated?: Point

Surgical Endoscopy and Other Interventional Techniques

Volumn 18, Issue 2, 2004, Pages 338-344

  Peters, J H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; DYSPLASIA; ESOPHAGUS ULCER; HUMAN; LAPAROSCOPIC SURGERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; STOMACH FUNDOPLICATION; TREATMENT INDICATION; TREATMENT OUTCOME; ULCER HEALING;

ADENOCARCINOMA; ANTACIDS; ANTI-ULCER AGENTS; BARRETT ESOPHAGUS; CLINICAL TRIALS; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; LAPAROSCOPY; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ULCER;

EID: 1542346399     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-003-8276-9     Document Type: Review

References (53)

1. Attwood SE, Barlow AP, Norris TL, Watson A (1992) Barrett's oesophagus: effect of antireflux surgery on symptom control and development of complications. Br J Surg 79: 1050-1053
2. Attwood SE, Smyrk TC, DeMeester TR, Mirvish SS, Stein HJ, Hinder RA (1992) Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 111: 503-510
3. Bammer T, Hinder RA, Klaus A, Klingler PJ (2001) Five to eight year outcome of the first laparoscopic Nissen fundoplications. J Gastrointest Surg 5: 42-48
4. Behar J, Sheahan DG, Biancani P, Spiro HM, Storer EH (1975) Medical and surgical management of reflux esophagitis. A 38-month report of a prospective clinical trial. N Engl J Med 293: 263-268
5. Bowers SP, Mattar SG, Smith CD, Waring JP, Hunter JG (2002) Clinical and histologic outcome after antireflux surgery in Barrett's esophagus. J Gastrointest Surg 6: 532-539
6. Cameron AJ (1999) Barrett's esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 94: 2054-2059
7. Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Mason RJ (1999) The pattern of esophageal acid exposure in gastroesophageal reflux disease influences the severity of the disease. Arch Surg 134: 882-887
8. Campos GM, Peters JH, DeMeester TR, et al. (1999) Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 3: 292-300
9. Carlson MA, Frantzidses CT (2001) Complications and results of primary minimally invasive antireflux procedures; a review of 10,735 reported cases. J Am Coll Surg 193: 428-439
10. Champion G, Richter JE, Vaezi MF, Singh S, Alexander R (1994) Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 107: 747-754
11. Chen LQ, Nastos D, Hu CY, et al. (1999) Results of the Collis-Nissen gastroplasty in patients with Barrett's esophagus. Ann Thorac Surg 68: 1014-1020
12. Costantini M, Zaninotto G, Anselmino M, Boccu C, Nicoletti L, Ancona E (1996) The role of a defective lower esophageal sphincter in the clinical outcome of treatment for gastroesophageal reflux disease. Arch Surg 131: 655-659
13. Csendes A, Braghetto I, Burdiles P, et al. (1998) Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation. Surgery 126: 645-657
14. Eisen GM, Sandler RS, Murray S, Gottfried M (1997) The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol 92: 27-31
15. Farrell TM, Smith CD, Metreveli RE, Johnson AB, Galloway KD, Hunter JG (1999) Fundoplication provides effective and durable symptom relief in patients with Barrett's esophagus. Am J Surg 178: 18-21
16. Fitzgerald RC, Omary MB, Triadafilopoulos G (1996) Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. J Clin Invest 98: 2120-2128
17. Gillen P, Keeling P, Byrne PJ, Healy M, O'Moore RR, Hennessy TP (1988) Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus. Br J Surg 75: 540-543
18. Glise H, Hallerback B, Johansson B (1995) Quality-of-life assessments in evaluation of laparoscopic Rosetti fundoplication. Surg Endosc 9: 183-188
19. Gurski RR, Peters JH, Hagen JA, DeMeester SR, Bremner CG, Chandrasoma PT, DeMeester TR (2003) Barrett's esophagus can and does regress following antireflux surgery; a study of prevalence and predictive features. J Am Coll Surg 196: 706-713
20. Heudebert GR, Marks R, Wilcox CM, Center RM (1997) Choice of long-term strategy for management of patients with severe esophagitis: a cost-utility analysis. Gastroenterology 112: 1078-1086
21. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl CV, Wong RKH (1999) Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction; prevalence and clinical data. Gastroenterology 116: 277-285
22. Hofstetter WA, Peters JH, DeMeester TR, Hagan JA, DeMeester SR, Crookes PF, Mason RA, Tsai P, Banki F, Bremner CG (2001) Long term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg 234: 532-539
23. Horvath KD, Jobe BA, Herron DM, Swanstrom LL (1999) The laparoscopic Toupet is an inadequate procedure for patients with severe reflux disease. J Gastrointest Surg 3: 583-591
24. Iascone C, DeMeester TR, Little AG, Skinner DB (1983) Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch surg 118: 543-549
25. Isolauri J, Luostarinen M, Viljakka M, et al. (1997) Long-term comparison of antireflux surgery versus conservative therapy for reflux esophagitis. Ann Surg 225: 295-299
26. Katzka DA, Castell DO (1994) Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 89: 989-991
27. Kauer WK, Burdiles P, Ireland AP, et al. (1995) Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. Am J Surg 169: 98-103
28. Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA (1995) Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 222: 525-531
29. Lundell L, Miettinen P, Myrvold HE, Pedersoen SA, Thor K, Lamm M, Blomqvist A, Hatlebakk JG, Janatuinnen E, Levander K, Nystrom P, Wiklund Ithe Nordic GORD study (2000) Long term management of gastro-oesopahgeal reflux disease with omeprazole or open antireflux surgery: results of a prospective randomized trial. Eur J Gastroenterol Hepatol 12: 879-887
30. McEntee GP, Stuart RC, Byrne PJ, Nolan N, Hennessy TPJ (1991) An evaluation of surgical and medical treatment of Barrett's oesophagus. Gullet 1: 169-172
31. Öberg S, DeMeester TR, Peters JH, et al. (1999) The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg 117: 572-580
32. Öberg S, Johansson H, Wenner J, Johnsson F, Zilling T, Holstein CS von, Nilsson J, Walther B (2001) Endoscopic surveillance of columnar lined esophagus; frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann Surg 234: 619-626
33. Öberg S, Ritter MP, Crookes PF, et al. (1998) Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett's esophagus and duodenogastroesophageal reflux. J Gastrointest Surg 2: 547-553
34. Ortiz A, Martinez Haro LF de, Parrilla P, et al. (1996) Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study. Br J Surg 83: 274-278
35. Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G (1999) Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology 117: 327-335
36. Ouatu-Lascar R, Triadafilopolous G (1998) Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 93: 711-716
37. Parrilla P, Martinez Haro LF de, Ortiz A, Munitiz V, Molina J, Bermejo J, Canteras M (2003) Long term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg 237: 291-298
38. Patti MG, Arcerito M, Feo CV, et al. (1999) Barrett's esophagus: a surgical disease. J Gastrointest Surg 3: 397-404
39. Peghini PL, Katz PO, Castell DO (1998) Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology 115: 1335-1339
40. Peters JH, DeMeester TR, Crookes PA, Oberg S, Vos Shoop M de, Hagen JA, Bremner CG (1998) The treatment of gastroesophageal reflux with laparoscopic fundoplication; prospective evaluation of 100 consecutive patients with typical symptoms. Ann Surg 228: 40-50
41. Sampliner RE, Fennerty B, Garewal HS (1996) Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 44: 532-535
42. Singh P, Taylor RH, Colin-Jones DG (1994) Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present. Am J Gastroenterol 89: 349-356
43. Spechler SJ (1992) Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 326: 786-792
44. Stein HJ, Barlow AP, DeMeester TR, Hinder RA (1992) Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 16: 35-43
45. Stein HJ, Hoeft S, DeMeester TR (1993) Functional foregut abnormalities in Barrett's esophagus. J Thorac Cardiovasc Surg 105: 107-111
46. Stein HJ, Kauer WK, Feussner H, Siewert JR (1998) Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and Nissen fundoplication. J Gastrointest Surg 2: 333-341
47. Trus TL, Laycock WS, Waring JP, Branum GD, Hunter JG (1999) Improvement in quality of life measures after laparoscopic antireflux surgery. Ann Surg 229: 331-336
48. Boom G Van Den, Go PM, Hameeteman W, Dallemagne B, Ament AJ (1996) Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands. Scand J Gastroenterol 31: 1-9
49. Vela M, Camacho-Lobato L, Hatlebakk J, Katz PO, Castell DO (1999) Effect of omeprazole (PPI) on ratio of acid to nonacid gastroesophageal reflux. Studies using simultaneous intraesophageal impedance and pH measurement. Gastroenterology p A1202
50. Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA (1996) Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183: 217-224
51. Viljakka M, Nevalainen J, Isolauri J (1997) Lifetime costs of surgical versus medical treatment of severe gastro-oesophageal reflux disease in Finland. Scand J Gastroenterol 32: 766-772
52. Watson DI, Jamieson GG, Baigrie RJ, Mathew G, Devitt PG, Game PA, Britten-Jones RB (1996) Laparoscopic surgery for gastroesophageal reflux; beyond the learning curve. Br J Surg 83: 1284-1287
53. Yau P, Watson DI, Devitt PG, Game PA, Jamieson GG (2000) Laparoscopic antireflux surgery in the treatment of gastroesophageal reflux in patients with Barrett's esophagus. Arch Surg 135:801-805